Our latest

18 November 2022

Hyris and Singlabs signed a distributorship agreement for Singapore

Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.

CONTINUE TO READING
02 November 2022

Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

Hyris and P.Intertrade Equipments will partner together to commercialize Hyris signature technology, Hyris System, and Hyris testing solutions in Thailand.

CONTINUE TO READING
27 September 2022

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

From October 5th to October 7th, Hyris will be present at the SIBioC 2022 in Genova, to present Hyris marketplace approach and Hyris System^TM disruptive featuresfor laboratory medicine.

CONTINUE TO READING
20 September 2022

Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

From September 22nd to September 24th, Hyris will be present at the SEI 2022 in Leon, to show the scientific approach related to our new T Cells test to monitor the cellular immunity to SARS-CoV-2.

CONTINUE TO READING

Products & Partnerships

18 November 2022

Hyris and Singlabs signed a distributorship agreement for Singapore

Products & Partnerships

02 November 2022

Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

27 September 2022

Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine

20 September 2022

Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia

Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2

Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

Hyris and its network want to make pragmatic impact Helping Ukrainian Families

21 December 2021

Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

Products & Partnerships

02 December 2021

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

Products & Partnerships

14 October 2021

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

15 September 2021

Hyris presents its new Brand, supporting its fast growth worldwide.

Products & Partnerships

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants - Update

The Canadian Olympic Committee and Canadian Paralympic Committee chose the HYRIS SYSTEM™ to effectively test Canadian National Sport Teams against Covid-19.

Products & Partnerships

22 February 2021

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants

11 February 2021

Lallemand Health Solutions choose the Hyris System™ for their internal certification protocol

Products & Partnerships

31 December 2020

Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection

20 October 2020

Industry Leaders Embrace Hyris' "Virus Finder System" to Keep Operations Running and Employees Safe

30 September 2020

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

Hyris Ltd first ranking for COVID-19 research fund program by Regione Lombardia

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment

Hyris COVID-19 Environmental Testing - Press Release

Products & Partnerships

17 February 2020

Generon - Hyris

Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2

Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

Hyris and its network want to make pragmatic impact Helping Ukrainian Families

21 December 2021

Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

Products & Partnerships

02 December 2021

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

Products & Partnerships

14 October 2021

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

15 September 2021

Hyris presents its new Brand, supporting its fast growth worldwide.

Products & Partnerships

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants - Update

The Canadian Olympic Committee and Canadian Paralympic Committee chose the HYRIS SYSTEM™ to effectively test Canadian National Sport Teams against Covid-19.

Products & Partnerships

22 February 2021

The Hyris System™ can detect SARS-CoV-2 despite all the novel variants

11 February 2021

Lallemand Health Solutions choose the Hyris System™ for their internal certification protocol

Subscribe our newsletter

For periodical updates about Hyris solutions.

Connect with us

Contact Us